Strategy
MSTR
153.37
-11.18
-6.79%
Strategy
US · MSTR
#396 by market cap
Listed 1970
153.37
-11.18
-6.79%
Live - 5344 symbols - heartbeat 119s ago
· 2026-10-08 08:30
Pre-market
150.80
-1.68%
After-hours
154.70
+0.87%
Overnight
152.21
-0.76%
- Market cap
- 64.72B
- P/E (TTM)i
- -1.58
- P/Bi
- 2.10
- EPSi
- -15.23
- Div yieldi
- 0.00%
- 52W posi
- 31%
Reader sentiment
Are you bullish or bearish on MSTR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.85, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.97% YoY
Margins
- Gross margin
- 68.69%
- Operating margin
- -8.57%
- Net margin
- -886.26%
Key ratios & quality
- Enterprise valuei
- 70.61B
- Altman Z-Scorei
- 3.85
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 497.64M | 486.33M | 480.74M | 510.76M | 499.26M | 496.26M | 463.46M | 477.23M |
| Gross profit | 398.14M | 386.35M | 389.68M | 418.85M | 396.28M | 386.32M | 333.99M | 327.82M |
| Selling & admin expenses | 291.66M | 277.93M | 229.05M | 255.64M | 258.30M | 264.98M | 278.62M | 274.87M |
| Research & development | 102.50M | 109.42M | 103.56M | 117.12M | 127.43M | 120.53M | 118.49M | 93.86M |
| Operating profit | 3.98M | -1.00M | 57.07M | 46.09M | 10.54M | 804.00K | -63.12M | -40.91M |
| Pretax profit | 20.48M | 38.26M | -19.95M | -811.39M | -1.32B | -124.53M | -1.93B | -5.53B |
| Tax | -2.02M | 3.91M | -12.43M | -275.91M | 147.33M | -553.65M | -767.69M | -1.68B |
| Net profit | 22.50M | 34.36M | -7.52M | -535.48M | -1.47B | 429.12M | -1.17B | -3.85B |
| Basic EPS | 0 | 0 | 0 | -5 | -13 | 3 | -6 | -15 |
| Diluted EPS | 0.20 | 0.33 | -0.08 | -5.34 | -12.98 | 2.64 | -6.06 | -15.23 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 111.07M | 114.49M | 128.69M | 122.99M | 124.30M | 122.37M |
| Gross profit | 77.10M | 78.74M | 90.68M | 81.31M | 83.35M | 81.55M |
| Selling & admin expenses | 68.08M | 70.19M | 68.08M | 68.51M | 73.63M | 74.04M |
| Research & development | 24.42M | 24.07M | 22.60M | 22.76M | 24.67M | 23.10M |
| Operating profit | -15.41M | -15.52M | -5.00K | -9.97M | -14.94M | -15.59M |
| Pretax profit | -5.94B | 14.01B | 3.87B | -17.46B | -14.47B | -8.22B |
| Tax | -1.73B | 3.98B | 1.09B | -5.02B | -1.92B | 1.56M |
| Net profit | -4.22B | 10.02B | 2.79B | -12.44B | -12.54B | -8.22B |
| Basic EPS | -16 | 36 | 9 | -43 | -38 | -24 |
| Diluted EPS | -16.49 | 32.60 | 8.42 | -42.93 | -38.25 | -24.45 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 778.40M | 753.45M | 272.62M | 267.97M | 264.57M | 267.90M | 252.32M | 2.56B |
| Cash & ST investments | 576.11M | 565.65M | 59.68M | 63.36M | 43.84M | 46.82M | 38.12M | 2.30B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 855.77M | 916.57M | 1.47B | 3.56B | 2.41B | 4.76B | 25.84B | 61.64B |
| Total current liabilities | 258.27M | 269.82M | 285.62M | 311.99M | 317.40M | 323.27M | 355.38M | 456.49M |
| Short-term debt | -- | -- | -- | -- | 454.00K | 483.00K | 517.00K | 31.31M |
| Long-term debt | -- | -- | 486.37M | 2.16B | 2.38B | 2.18B | 7.19B | 8.16B |
| Total liabilities | 326,037,000.00 | 408,012,000.00 | 912,567,000.00 | 2,578,166,000.00 | 2,793,392,000.00 | 2,597,556,000.00 | 7,613,701,000.00 | 10,598,110,000.00 |
| Total equity | 529.73M | 508.56M | 553.05M | 978.96M | -383.12M | 2.16B | 18.23B | 51.04B |
| Retained earnings | 549.13M | 583.49M | 575.97M | 41.44M | -1.43B | -999.23M | -2.17B | 6.32B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 203.61M | 213.46M | 213.95M | 2.56B | 2.39B | 2.67B |
| Cash & ST investments | 60.30M | 50.10M | 54.29M | 2.30B | 2.21B | 2.45B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 43.92B | 64.77B | 73.62B | 61.64B | 54.27B | 52.56B |
| Total current liabilities | 308.69M | 314.57M | 324.09M | 456.49M | 395.06M | 495.11M |
| Short-term debt | 525.00K | 349.00K | 316.00K | 31.31M | 31.40M | 39.81M |
| Long-term debt | 8.14B | 8.16B | 8.17B | 8.16B | 8.17B | 6.67B |
| Total liabilities | 10,394,027,000.00 | 14,402,450,000.00 | 15,501,990,000.00 | 10,598,110,000.00 | 8,632,465,000.00 | 7,235,609,000.00 |
| Total equity | 33.53B | 50.37B | 58.12B | 51.04B | 45.64B | 45.33B |
| Retained earnings | 6.35B | 16.32B | 18.95B | 6.32B | -6.47B | -15.20B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10.63M | 60.87M | 53.62M | 93.83M | 3.21M | 12.71M | -53.03M | -67.24M |
| Depreciation & amortization | 3.70M | 8.59M | 13.33M | 11.36M | 10.87M | 14.53M | 17.81M | 25.52M |
| Free cash flow | 3.78M | 50.69M | -1.08B | -2.54B | -287.20M | -1.89B | -22.14B | -22.58B |
| Dividends paid | -- | -- | -- | -- | -- | 0 | 0 | -381.37M |
| Stock buybacks / issuance | -110.98M | -72.72M | -123.22M | 1.00B | 46.59M | 2.03B | 16.36B | 16.27B |
| Ending cash balance | 110.79M | 457.82M | 60.76M | 64.43M | 50.87M | 48.67M | 39.90M | 2.30B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.39M | -34.91M | -8.31M | -21.63M | 13.99M | -4.14M |
| Depreciation & amortization | 6.58M | 9.12M | 4.20M | 5.63M | 8.79M | 12.36M |
| Free cash flow | -7.67B | -6.82B | -4.97B | -3.12B | -7.24B | -6.43B |
| Dividends paid | -9.19M | -48.95M | -139.78M | -183.45M | -229.53M | -399.65M |
| Stock buybacks / issuance | 4.41B | 5.26B | 2.20B | 4.41B | 5.30B | 2.95B |
| Ending cash balance | 62.26M | 52.13M | 56.20M | 2.30B | 2.21B | 1.71B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.02 | 6.62 | -1.42 | -69.91 | -493.35 | 48.17 | -11.44 | -13.57 |
| ROA %i | 2.66 | 3.88 | -0.63 | -21.32 | -49.26 | 11.97 | -7.62 | -9.67 |
| ROIC %i | 2.47 | 3.94 | -0.93 | -24.71 | -55.73 | 14.38 | -7.56 | -10.75 |
| 5-year avg ROE %i | 10.83 | 11.84 | 6.12 | -11.52 | -110.82 | -101.98 | -105.59 | -108.02 |
| EBIT margin %i | 0.80 | -0.21 | 11.87 | 9.02 | 2.11 | -15.23 | -404.01 | -1,144.30 |
| FCF / sales %i | 0.76 | 10.42 | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.01 | 2.79 | 0.95 | 0.86 | 0.83 | 0.83 | 0.71 | 5.62 |
| Quick ratioi | 2.89 | 2.70 | 0.90 | 0.81 | 0.73 | 0.71 | 0.62 | 5.49 |
| Debt / assetsi | 0.00 | 11.28 | 38.94 | 62.74 | 101.50 | 47.11 | 28.05 | 13.36 |
| LT debt / equityi | -- | 20.34 | 103.19 | 227.97 | -- | 103.61 | 39.76 | 18.60 |
| Interest coveragei | -- | -- | -- | -- | -- | -1.54 | -30.23 | -84.06 |
| Revenue CAGR (3Y) %i | -2.07 | -1.80 | -1.55 | 0.87 | 0.88 | 1.07 | -3.19 | -1.49 |
| Net income CAGR (3Y) %i | -40.33 | -28.05 | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -69.75 | -22.35 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -30.86 | 18.82 | 27.52 | -13.57 | -37.09 | -80.06 |
| ROA %i | -21.25 | 13.18 | 18.84 | -9.67 | -26.02 | -53.47 |
| ROIC %i | -22.81 | 15.33 | 22.66 | -10.75 | -29.94 | -67.09 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -1,653.85 | 1,433.54 | 2,311.49 | -1,144.30 | -1,113.33 | -7,266.26 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.66 | 0.68 | 0.66 | 5.62 | 6.05 | 5.39 |
| Quick ratioi | 0.53 | 0.53 | 0.52 | 5.49 | 5.90 | 5.19 |
| Debt / assetsi | 18.66 | 12.68 | 11.17 | 13.36 | 15.22 | 12.88 |
| LT debt / equityi | 25.43 | 17.30 | 15.71 | 18.60 | 22.44 | 21.79 |
| Interest coveragei | -113.09 | 95.23 | 156.03 | -84.06 | -- | -587.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
software100.00%
Quote time 2026-10-08 08:30:10 · For reference only, not investment advice and not tailored to your situation.